Tab. 3.
Detailed changes in TAPSE, RV FAC and MAPSE parameters according to heart defects in particular measurements before the surgery (measurement 0) and after surgery (measurement 1, 2, 3) – median and quartile distribution
| ASD N = 4 | Measurement 0 | Measurement 1 | Measurement 2 | Measurement 3 | |
| TAPSE (mm) | 16.60 (14.97–21.22) | 7.00 (3.72–9.46) | 7.77 (6.74–8.67) | 7.68 (6.62–8.75) | |
| MAPSE (mm) | 6.95 (6.46–10.99) | 6.12 (4.98–7.99) | 6.88 (6.56–8.99) | 11.71 (8.57–14.85) | |
| RV FAC (%) | 32.66 (0.00–52.11) | 48.75 (39.28–51.31) | 50.66 (44.06–70.12) | 39.11 (37.21–41.02) | |
| VSD N = 26 | Measurement 0 | Measurement 1 | Measurement 2 | Measurement 3 | |
| TAPSE (mm) | 15.17 (12.62–18.28) | 4.98 (4.18–5.98) | 6.11 (5.40–7.31) | 7.44 (6.80–8.25) | |
| MAPSE (mm) | 8.04 (7.02–9.30) | 6.07 (5.47–6.70) | 6.59 (5.69–7.55) | 7.20 (7.02–8.41) | |
| RV FAC (%) | 43.94 (37.50–52.00) | 59.25 (48.15–61.90) | 52.83 (48.48–58.33) | 54.65 (52.33–59.31) | |
| ToF N = 9 | Measurement 0 | Measurement 1 | Measurement 2 | Measurement 3 | |
| TAPSE (mm) | 15.20 (14.63–17.50) | 4.60 (3.60–5.65) | 6.55 (5.97–7.07) | 8.17 (6.49–9.21) | |
| MAPSE (mm) | 8.27 (6.66–9.27) | 5.66 (5.10–8.27) | 7.73 (6.31–9.39) | 9.01 (8.95–9.72) | |
| RV FAC (%) | 39.39 (35.08–46.66) | 49.31 (34.84–59.54) | 54.17 (50.75–59.57) | 55.17 (39.39–61.53) | |
| AVSD N = 12 | Measurement 0 | Measurement 1 | Measurement 2 | Measurement 3 | |
| TAPSE (mm) | 15.47 (13.28–18.98) | 4.82 (3.97–5.71) | 6.2 (5.11–7.02) | 8.47 (6.57–8.78) | |
| MAPSE (mm) | 7.21 (6.74–8.29) | 5.78 (5.46–6.92) | 7.33 (6.14–8.25) | 7.91 (7.15–9.00) | |
| RV FAC (%) | 42.11 (30.76–43.85) | 53.97 (42.32–59.58) | 54.97 (50.00–60.00) | 56.01 (50.00–68.86) |